Oppenheimer Increases Salesforce (NYSE:CRM) Price Target to $275.00
Salesforce (NYSE:CRM – Free Report) had its price objective upped by Oppenheimer from $250.00 to $275.00 in a report issued on Thursday morning, Marketbeat.com reports. They currently have an outperform rating on the CRM provider’s stock. Several other analysts have also recently commented on CRM. Citigroup lifted their price target on Salesforce from $229.00 to […]
More Stories
Zotefoams (LON:ZTF) Hits New 1-Year Low – Here’s Why
Zotefoams plc (LON:ZTF – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock...
Mineralys Therapeutics (NASDAQ:MLYS) Shares Down 9.6% – Here’s Why
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report)’s stock price traded down 9.6% on Wednesday . The company traded as...
Britvic (LON:BVIC) Hits New 12-Month High – Should You Buy?
Britvic plc (LON:BVIC – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday ....
RBG (LON:RBGP) Sets New 12-Month Low – Time to Sell?
Shares of RBG Holdings plc (LON:RBGP – Get Free Report) hit a new 52-week low during trading on Wednesday ....
Lattice Semiconductor Adopts 2025 Inducement Equity Incentive Plan
Lattice Semiconductor Corporation, a Delaware-based company specializing in semiconductor technology, announced on January 9, 2025, the adoption of the Lattice...
Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 3.9% – Here’s What Happened
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report)’s stock price shot up 3.9% during trading on Wednesday . The stock...